Veeral H Ajmera

29PUBLICATIONS
76CO-AUTHORS
Medical biochemistry - nucleic acidsBehavioural epidemiologyMedical biochemistry - lipidsComparative language studiesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 10, 2026
Letter: Beyond Feasibility-The Need for Longer Duration and Composite NIT Endpoints in Biopsy-Free MASH Trials: Authors' Reply.

|Apr 22, 2026
Spontaneous Recovery and Mortality in Patients With ALD Referred for Early Liver Transplantation.

|Feb 17, 2026
Letter on 'Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)'; Authors' reply.

Kaleb Tesfai, Luis Antonio Díaz, Veeral Ajmera

|Nov 12, 2025
Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non-Lean Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease-Authors' Reply.

Kaleb Tesfai, Luis Antonio Díaz, Veeral Ajmera

|Oct 28, 2025
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab

|Sep 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease.

Luis Antonio Diaz, Maja Thiele, Alexandre Louvet

Pageof 5

Frequent Collaborators

12 joint publications

Rohit Loomba

5 joint publications

Luis Antonio Díaz

4 joint publications

Kaleb Tesfai

4 joint publications

Monica Tincopa